Article
Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.
Scientific reports - 24 Aug 2024
Nehru Vijayalakshmi Jawaharlal, Jose Vandakunnel Maria, Brammacharry Usharani, Ramachandra Venkateswari, Pradhabane Gunavathy, Mani Balasundaram Revathi, Vn Azger Dusthackeer, Muthaiah Muthuraj
Abstract excerpt
Fluoroquinolone resistance is a major challenge in treating Multidrug-Resistant Tuberculosis globally. The GenoType MTBDRsl Ver 2.0, endorsed by the WHO, was used to characterize fluoroquinolone resistance. The fluoroquinolone resistance rates in the MDR-TB, Rifampicin-Resistant TB, and non-MDR-TB were 33%, 16.5%, and 5.4%, respectively. The most common mutation found in fluoroquinolone-resistant isolates was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
